LORANGER STEVEN R has filed 8 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 3528 shares of Edwards Lifesciences Corp ($EW) on May 09, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | A | Common Stock | 3528 | $0.00 | 78,900.0000 | 655,900,000 | 4.68% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | A | Common Stock | 1154 | $0.00 | 80,054.0000 | 655,900,000 | 1.46% | 0.00% |
| Feb. 14, 2025 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | M | Common Stock | 5739 | $45.32 | 81,111.0000 | 654,800,000 | 7.61% | 0.00% |
| Feb. 14, 2025 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | S | Common Stock | 5739 | $76.42 | 75,372.0000 | 654,800,000 | 7.08% | 0.00% |
| Feb. 14, 2025 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | M | Director Stock Option (Right to Acquire) | 5739 | $0.00 | 0.0000 | 654,800,000 | 100.00% | 0.00% |
| May 8, 2024 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | A | Common Stock | 3055 | $0.00 | 74,373.0000 | 651,800,000 | 4.28% | 0.00% |
| May 8, 2024 | Edwards Lifesciences Corp | $EW | LORANGER STEVEN R | Director | A | Common Stock | 999 | $0.00 | 75,372.0000 | 651,800,000 | 1.34% | 0.00% |
| May 18, 2023 | Xylem Inc. | $XYL | LORANGER STEVEN R | Not found | A | Common Stock | 1580 | $0.00 | 60,225.0000 | 181,000,000 | 2.69% | 0.00% |